In the HYPNO trial, was there a difference in 3 year locoregional control between moderate hypofractionation and conventional fractionation for locally advanced head and neck cancer?
Patients with a low score (<25th percentile) on the PORTAL nomogram have what rate of 2 year ADT free survival after metastasis directed therapy alone for oligometastatic prostate cancer?
In a large retrospective series from the VA of patients with synchronous primary lung cancers, what treatment modality had the highest rate of overall survival?
Is there a difference in cancer specific survival for focal therapy (HIFU or cryo) versus salvage prostatectomy for radiorecurrent prostate cancer?
Answers
No, 51% in both arms. 3 year OS was 54.1% with 55 Gy in 20 fractions versus 55.5% with 66 Gy in 33 fractions.
84.1% compared to 71.3% for intermediate scores and 44.9% for high scores.
Surgery for all lesions. Granted, surgical patients were significantly younger and had fewer comorbidities than those referred for SBRT, which likely influenced survival in these populations. Utilization of SBRT increased significantly over time, and survival improved over time for all treatment modalities.
No. 92% v 99% at 5 years. Prior to 5 years, survival favored focal therapy while survival beyond 5 years favored prostatectomy. | QuadShot News
Patients with a low score (<25th percentile) on the PORTAL nomogram have what rate of 2 year ADT free survival after metastasis directed therapy alone for oligometastatic prostate cancer?
In a large retrospective series from the VA of patients with synchronous primary lung cancers, what treatment modality had the highest rate of overall survival?
Is there a difference in cancer specific survival for focal therapy (HIFU or cryo) versus salvage prostatectomy for radiorecurrent prostate cancer?
Answers
No, 51% in both arms. 3 year OS was 54.1% with 55 Gy in 20 fractions versus 55.5% with 66 Gy in 33 fractions.
84.1% compared to 71.3% for intermediate scores and 44.9% for high scores.
Surgery for all lesions. Granted, surgical patients were significantly younger and had fewer comorbidities than those referred for SBRT, which likely influenced survival in these populations. Utilization of SBRT increased significantly over time, and survival improved over time for all treatment modalities.
No. 92% v 99% at 5 years. Prior to 5 years, survival favored focal therapy while survival beyond 5 years favored prostatectomy. | QuadShot News